Approval · Notice of Compliance 19861 · 2017
PROPOFOL: Notice of Compliance 19861
Issued September 29, 2017
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 19861
- Date
- September 29, 2017
- Company
- Baxter CorporationMississauga, Ontario, Canada
- Product type
- Prescription Pharmaceutical
- Submission
- Abbreviated New Drug Submission (ANDS)
- Submission class
- Admin
- Reason
- Licensing agreement between two companies
- Canadian reference product
- DIPRIVAN
Products in this notice
| Brand | DIN | Status today |
|---|---|---|
| PROPOFOL | 02468336 | Cancelled Post Market |
Medicinal ingredients
- PROPOFOL 10 MG per ML